Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria A Rodriguez

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
Blood Advances|March 31, 2022
SIRPα+ macrophages are increased in patients with FL who progress or relapse after frontline lenalidomide and rituximabMario L Marques-Piubelli, Edwin R Parra, Lei Feng, et al.
Blood Advances|May 1, 2019
Favorable outcomes with de-escalated radiation therapy for limited-stage nodular lymphocyte-predominant Hodgkin lymphomaChelsea C Pinnix, Sarah A Milgrom, Chan Yoon Cheah, et al.
Blood|May 20, 2017
Encouraging activity for R-CHOP in advanced stage nodular lymphocyte-predominant Hodgkin lymphomaMichelle A Fanale, Chan Yoon Cheah, Amy Rich, et al.
The Lancet. Haematology|June 6, 2024
Response-adapted ultra-low-dose 4 Gy radiation as definitive therapy of gastric MALT lymphoma: a single-centre, pilot trialJillian R Gunther, Jie Xu, Manoop S Bhutani, et al.
Blood|February 3, 2021
Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphomaPaolo Strati, Sairah Ahmed, Fateeha Furqan, et al.
Blood Advances|July 15, 2021
CRP and ferritin in addition to the EASIX score predict CAR-T-related toxicityUri Greenbaum, Paolo Strati, Rima M Saliba, et al.
Blood Advances|August 22, 2020
Clinical and radiologic correlates of neurotoxicity after axicabtagene ciloleucel in large B-cell lymphomaPaolo Strati, Loretta J Nastoupil, Jason Westin, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Blood Advances|March 31, 2022
SIRPα+ macrophages are increased in patients with FL who progress or relapse after frontline lenalidomide and rituximabMario L Marques-Piubelli, Edwin R Parra, Lei Feng, et al.
Blood Advances|May 1, 2019
Favorable outcomes with de-escalated radiation therapy for limited-stage nodular lymphocyte-predominant Hodgkin lymphomaChelsea C Pinnix, Sarah A Milgrom, Chan Yoon Cheah, et al.
Blood|May 20, 2017
Encouraging activity for R-CHOP in advanced stage nodular lymphocyte-predominant Hodgkin lymphomaMichelle A Fanale, Chan Yoon Cheah, Amy Rich, et al.
The Lancet. Haematology|June 6, 2024
Response-adapted ultra-low-dose 4 Gy radiation as definitive therapy of gastric MALT lymphoma: a single-centre, pilot trialJillian R Gunther, Jie Xu, Manoop S Bhutani, et al.
Blood|February 3, 2021
Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphomaPaolo Strati, Sairah Ahmed, Fateeha Furqan, et al.
Blood Advances|July 15, 2021
CRP and ferritin in addition to the EASIX score predict CAR-T-related toxicityUri Greenbaum, Paolo Strati, Rima M Saliba, et al.
Blood Advances|August 22, 2020
Clinical and radiologic correlates of neurotoxicity after axicabtagene ciloleucel in large B-cell lymphomaPaolo Strati, Loretta J Nastoupil, Jason Westin, et al.
Pageof 8